New York S 6851: Relates to establishing requirements for restraining dogs outdoors

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S06851 Summary:

BILL NOS06851 

&nbsp

SAME ASSAME AS A03426

&nbsp

SPONSORWEBB

&nbsp

COSPNSR

&nbsp

MLTSPNSR

&nbsp

Add Art 29-H §2999-ff, Pub Health L; add §6801-b, Ed L; amd §5, Chap 21 of 2011

&nbsp

Authorizes physicians and pharmacists to enter into collaborative practice medication adherence protocols for their patients; makes permanent certain provisions relating to authorizing pharmacists to perform with physicians in certain settings.

Go to top S06851 Actions:

BILL NOS06851 

&nbsp

03/25/2025REFERRED TO HEALTH

04/29/2025REPORTED AND COMMITTED TO FINANCE

06/09/2025COMMITTEE DISCHARGED AND COMMITTED TO RULES

06/09/2025ORDERED TO THIRD READING CAL.1637

06/10/2025PASSED SENATE

06/10/2025DELIVERED TO ASSEMBLY

06/10/2025referred to higher education

01/07/2026died in assembly

01/07/2026returned to senate

01/07/2026REFERRED TO HEALTH

Go to topS06851 Committee&nbspVotes:

Go to topS06851 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS06851 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 6851

 2025-2026 Regular Sessions

 IN SENATE

 March 25, 2025
 ___________

 Introduced by Sen. WEBB -- read twice and ordered printed, and when
 printed to be committed to the Committee on Health

 AN ACT to amend the public health law and the education law, in relation
 to collaborative practice medication adherence; and to amend chapter
 21 of the laws of 2011 amending the education law relating to author-
 izing pharmacists to perform collaborative drug therapy management
 with physicians in certain settings, in relation to making the
 provisions of such chapter permanent

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. This act shall be known and may be cited as the "Collabora-
 2 tive Practice Medication Adherence Act".
 3 § 2. The public health law is amended by adding a new article 29-H to
 4 read as follows:
 5 ARTICLE 29-H
 6 COLLABORATIVE PRACTICE MEDICATION ADHERENCE ACT
 7 Section 2999-ff. Collaborative practice medication adherence.
 8 § 2999-ff. Collaborative practice medication adherence. 1. Defi-
 9 nitions. As used in this article, the following terms shall have the
 10 following meanings:
 11 (a) Qualified pharmacist. The term "qualified pharmacist" shall mean a
 12 pharmacist who maintains a current unrestricted license pursuant to
 13 article one hundred thirty-seven of the education law, who has a minimum
 14 of two years of experience in patient care as a practicing pharmacist
 15 within the last five years, and who has demonstrated competency in medi-
 16 cation adherence of patients with a chronic disease or diseases, includ-
 17 ing, but not limited to, the completion of one or more programs which
 18 are accredited by the accreditation council for pharmacy education,
 19 recognized by the education department and acceptable to the patient's
 20 treating physician.

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD05735-01-5

 S. 6851 2

 1 (b) Patient care. The term "patient care" shall mean assessing the
 2 appropriateness of prescription and non-prescription drugs for individ-
 3 ual patients based on an assessment of the patient's medication history,
 4 medication experience including beliefs, concerns, understanding and
 5 expectations, the clinical goals of therapy, potential drug-to-drug
 6 interactions or other medication safety concerns, recommendations for
 7 adherence and consulting with a patient or caregiver.
 8 (c) Collaborative practice medication adherence. The term "collabora-
 9 tive practice medication adherence" shall mean a program conducted by a
 10 qualified pharmacist that ensures a patient's medications, whether
 11 prescription or nonprescription, are individually assessed to determine
 12 that each medication is appropriate for the patient, effective for the
 13 medical condition, safe given the comorbidities and other medications
 14 being taken, and able to be taken by the patient as intended. Collabora-
 15 tive practice medication adherence protocols conducted by a qualified
 16 pharmacist shall include sharing of applicable patient clinical informa-
 17 tion with the